Will the Stryker Corporation -MAKO Surgical Corp. Deal Lead to More Action in Ortho?

free biotech news

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Could Stryker’s blockbuster $1.65 billion deal for robotic surgery player Mako Surgical augur for more consolidation in the orthopedics space? Stryker (NYSE:SYK) certainly found a way to liven up the ortho space, with Wednesday’s announcement that it is buying Mako Surgical (NSDQ:MAKO) for a whopping 13 times 2013 estimated revenue. Stryker had been pretty clear about its intentions to put cash towards M&A, and Stryker’s relative challenges in knees were already known, but few industry-watchers saw this deal coming, and certainly not at this price.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC